Ignite Creation Date:
2024-05-06 @ 9:07 AM
Last Modification Date:
2024-10-26 @ 12:09 PM
Study NCT ID:
NCT02900651
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-06-20
First Post:
2016-09-02
Brief Title:
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-10-03
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-27
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-09-27
Completion Date Type:
ESTIMATED
First Submit Date:
2016-09-02
First Submit QC Date:
September 9 2016
Study First Post Date:
2016-09-14
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-02
Last Update Post Date:
2024-06-20
Last Update Post Date Type:
ACTUAL